May 15, 2014: Denver, Colorado
“How are you feeling today, Amanda?” Dr. Wells checked the readout on the blood pressure monitor, his attention only half on his bored-looking teenage patient. This was old hat by now, to the both of them. “Any pain, weakness, unexplained bleeding, blurriness of vision…?”
“Nope. All systems normal, no danger signs here.” Amanda Amberlee let her head loll back, staring up at the colorful mural of clouds and balloons that covered most of the ceiling. She remembered when the staff had painted that for her. She’d been thirteen, and they’d wanted her to feel at ease as they pumped her veins full of a deadly disease designed to kill the disease that was already inside her. “Are we almost done? I have a fitting to get to.”
“Ah.” Dr. Wells, who had two teenage girls of his own, smiled. “Prom?”
“Prom,” Amanda confirmed.
“I’ll see what I can do.” Dr. Wells took impatience and surliness as insults from most patients. Amanda was a special case. When he’d first started treating her, her leukemia had been so advanced that she had no energy for complaining or talking back. She’d submitted to every test and examination willingly, although she had a tendency to fall asleep in the middle of them. From her, every snippy comment and teenage eye roll was a miracle, one that could be attributed entirely to science.
Marburg EX19—what the published studies were starting to refer to as “Marburg Amberlee,” after the index case, rather than “Marburg Denver,” which implied an outbreak and would be bad for tourism—was that miracle. The first effective cancer cure in the world, tailored from one of the most destructive viruses known to man. At thirteen, Amanda Amberlee had been given at most six months to live. Now, at eighteen, she was going to live to see her grandchildren… and none of them would ever need to be afraid of cancer. Like smallpox before it, cancer was on the verge of extinction.
Amanda lifted her head to watch him draw blood from the crook of her elbow. Any fear of needles she may have had as a child had died during the course of her cancer treatments. “How’s my virus doing?” she asked.
“I haven’t tested this sample yet, but if it’s anything like the last one, your virus should be fat and sleepy. It’ll be entirely dormant within another year.” Dr. Wells gave her an encouraging look. “After that, I’ll only need to see you every six months.”
“Not to seem ungrateful or anything, but that’ll be awesome.” The kids at her high school had mostly stopped calling her “bubble girl” once she was healthy enough to join the soccer team, but the twice-monthly appointments were a real drain on her social calendar.
“I understand.” Dr. Wells withdrew the needle, taping a piece of gauze down over the small puncture. Only a drop of blood managed to escape. “All done. And have a wonderful time at prom.”
Amanda slid out of the chair, stretching the kinks out of her back and legs. “Thanks, Dr. Wells. I’ll see you in two weeks.”
Daniel Wells smiled as he watched the girl who might well represent the future of mankind walk out of his office. A world without cancer. What a beautiful thing that would be.
Dr. Daniel Wells of the Colorado Cancer Research Center admitted in an interview this week that he was “guardedly optimistic” about having a universal cure for cancer by the end of the decade. His protocol was approved for human testing five years ago, and thus far, all subjects have shown improvement in their conditions…
May 15, 2014: Reston, Virginia
The misters nested in the ceiling above the feeding cages went off promptly at three, filling the air in the hot room with an aerosolized mixture of water and six different strains of rhinovirus. The feeding cages were full of rhesus monkeys and guinea pigs that had entered five minutes earlier, when the food was poured. They ignored the thin mist drifting down on them, their attention remaining focused entirely on the food. Dr. Alexander Kellis watched them eat, making notes on his tablet with quick swipes of his index finger. He didn’t look down.
“How’s it looking?”
“This is their seventh exposure. So far, none of them have shown any symptoms. Appetites are good, eyes are clear; no runny noses, no coughing. There was some sneezing, but it appears that Subject 11c has allergies.”
The man standing next to America’s premier expert in genetically engineered rhino-and coronaviruses raised an eyebrow. “Allergies?”